Wednesday, June 7, 2023
WebMD Global requires each individual who is in a position to control the content of one of its educational activities to disclose any relevant financial relationships occurring within the past 12 months that could create a conflict of interest.
Professor of Medicine
University of Toronto
Director of the Renal Physiology Laboratory
University Health Network (UHN)
Toronto, Ontario, Canada
Director
Kushner Wellness Center
Clinical Professor of Family Medicine University of California
Irvine, California
Innovation Officer
Institut Català de la Salut
Associate Professor
Universitat Autònoma de Barcelona
Catalonia, Spain
This activity has been peer reviewed and the reviewer has disclosed no relevant financial relationships.
This educational activity is intended for an international audience of non-US primary care physicians, nephrologists, and diabetologists and endocrinologists.
The goal of this activity is to increase physicians' knowledge, competence, and confidence in the early detection, screening, diagnosis, and management of patients at risk for chronic kidney disease (CKD), including patients with and without type 2 diabetes (T2D).
Upon completion of this activity, participants will:
WebMD Global requires each individual who is in a position to control the content of one of its educational activities to disclose any relevant financial relationships occurring within the past 12 months that could create a conflict of interest.
Professor of Medicine
University of Toronto
Director of the Renal Physiology Laboratory
University Health Network (UHN)
Toronto, Ontario, Canada
Director
Kushner Wellness Center
Clinical Professor of Family Medicine University of California
Irvine, California
Innovation Officer
Institut Català de la Salut
Associate Professor
Universitat Autònoma de Barcelona
Catalonia, Spain
This activity has been peer reviewed and the reviewer has disclosed no relevant financial relationships.
The Faculty of Pharmaceutical Medicine of the Royal Colleges of Physicians of the United Kingdom (FPM) has reviewed and approved the content of this educational activity and allocated it 0.50 continuing professional development credits (CPD).
For questions regarding the content of this activity, contact the accredited provider for this CME/CE activity noted above. For technical assistance, contact [email protected]
There are no fees for participating in or receiving credit for this online educational activity. For information about your
eligibility to claim
credit, please consult your professional licensing board.
This activity is designed to be completed within the time designated on the title page; physicians should claim only those
credits that reflect the
time actually spent participating in the activity. To successfully earn credit, participants must complete the activity online
during the credit
eligibility period that is noted on the title page.
Follow these steps to claim a credit certificate for completing this activity:
We encourage you to complete an Activity Evaluation to provide feedback for future programming.
You may now view or print the certificate from your CME/CE Tracker. You may print the certificate but you cannot alter it.
Credits will be tallied
in your CME/CE Tracker and archived for 6 years; at any point within this time period you can print out the tally as well
as the certificates by
accessing "Edit Your Profile" at the top of your Medscape homepage.
*The credit that you receive is based on your user profile.
CPD Released: 7/2/2021
Valid for credit through: 7/2/2022
processing....
Este comentario es parte de una actividad educativa más extensa. Después de participar, vuelva a SGLT2 Inhibitors in Primary Care: Detection, Early Initiation, and Management of CKD in Patients With and Without Type 2 Diabetes para acceder a todo el contenido educativo relacionado.
| « Return to: SGLT2 Inhibitors in Primary Care: Detection, Early Initiation, and Management of CKD in Patients With and Without Type 2 Diabetes |
